DOCSLIB.ORG

The Pharmacologically Improved Human. Performance-Enhancing

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Pharmacologically Improved Human. Performance-Enhancing OFFICEOFFICE OFOF TECHNOLOGYTECHNOLOGY ASSESSMENTASSESSMENT ATAT THETHE GERMANGERMAN BUNDESTAGBUNDESTAG Arnold Sauter Katrin Gerlinger The Pharmacologically Improved Human Performance-Enhancing Substances as a Social Challenge Final Report Technology Assessment Studies Series, No 5 THE PHARMACOLOGICALLY IMPROVED HUMAN TECHNOLOGY ASSESSMENT STUDIES SERIES, NO 5 The Office of Technology Assessment at the German Bundestag is an independ- ent scientific institution created with the objective of advising the German par- liament and its committees on matters relating to research and technology. TAB is operated by the Institute for Technology Assessment and Systems Analy- sis (ITAS) at the Karlsruhe Research Centre. In executing its working pro- gramme the Karlsruhe Research Centre cooperates with the Fraunhofer-Institut für System- und Innovationsforschung (ISI), Karlsruhe. TAB’s task is to design and implement technology assessment (TA) projects and to monitor and analyse important scientific and technological trends and the associated social developments (Monitoring, Future- and Innovation Reports, Policy-Benchmarking Reports). Arnold Sauter Katrin Gerlinger THE PHARMACOLOGICALLY IMPROVED HUMAN PERFORMANCE-ENHANCING SUBSTANCES AS A SOCIAL CHALLENGE Report for the Committee on Education, Research and Technology Assessment of the German Bundestag OFFICEOFFICE OFOF TECHNOLOGYTECHNOLOGY ASSESSMENTASSESSMENT ATAT THETHE GERMANGERMAN BUNDESTAGBUNDESTAG NOTE The orientation and content of this report cannot be taken as indicating the po- sition of the German Bundestag or its Committees. The German Bundestag retains the copyright to this publication. Reproduction is authorised, except for commercial purposes, but full acknowledgement is re- quested. A PDF-Version of the report is currently available on the Internet at the address http://www.tab-beim-bundestag.de. This title was first published in German language. The bibliographic informa- tion of the German title is: Arnold Sauter, Katrin Gerlinger: Der pharmako- logisch verbesserte Mensch. Leistungsteigernde Mittel als gesellschaftliche Herausforderung. Berlin: edition sigma 2012, ISBN 978-3-8360-8134-4. Translation: Michael Capone Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag (TAB) (Office of Technology Assessment at the German Bundestag) Neue Schönhauser Straße 10 10178 Berlin Germany Fon: +49 30 28 491-0 Fax: +49 30 28 491-119 [email protected] http://www.tab-beim-bundestag.de/ 2013 THE COMMITTEE’ S PREFACE For some years now, in response to the rising challenges of global socioeconomic competition, both the scientific community and the public have been debating whether the improvement of individuals’ performance with the help of technical or biomedical interventions in the human body – termed enhancement – is a welcome, inevitable or undesirable vision of the future. The report on brain research by the Office of Technology Assessment at the German Bundestag (TAB) (Bundestag printed paper 16/7821) also presented evidence of a growing trend towards the use of pharmaceuticals and other medi- cal interventions to specifically influence mental states and capacities. Following publication of the highly respected TAB report »Gene Doping«, an analysis of physical performance enhancement in sport, the Committee for Edu- cation, Research and Technology Assessment commissioned the TAB to under- take a technology assessment project on »pharmacological and technical inter- ventions to improve performance – prospects for more widespread use in medi- cine and everyday life« (»Enhancement Project«). The TAB’s final report analyzes the areas of development and use with the greatest social and political relevance now and in the foreseeable future, i.e. cur- rent developments and plausible trends regarding the use of psychopharmaceuti- cals and other drugs to enhance performance in working and everyday life. It provides a comprehensive analysis of the current status of possibilities to influ- ence human performance by pharmacological means and of the classification of those agents within the framework of laws regulating medicines, foods and healthcare. This will facilitate a realistic discussion of future developments that clearly stands out from previous hypothetical and visionary descriptions of en- hancement. The report shows that the targeted development and use of pharma- cological substances for nontherapeutic performance enhancement is incompati- ble with the current objectives of the medical innovation system and the remit of doctors. A change in this situation would require a far-reaching public and polit- ical opinion-forming process. At the same time, the systematic analysis of the scientific approach to the doping problem in elite and competitive sport under- taken in the TAB report points to the need for a thorough public debate on how to deal with growing demands for performance and innate differences in abilities among individuals. The report examines the options for action in the fields of research, regulation, healthcare consumer protection and prevention. 6 THE COMMITTEE’S PREFACE This report places in the hands of the Bundestag an up-to-date and highly de- tailed informational basis for parliamentary debate on this important aspect of research, health, legal, economic and social policies. Berlin, November 22, 2011 The Committee on Education, Research and Technology Assessment Ulla Burchardt, Member of the German Bundestag Committee Chairwoman Dr Thomas Feist, Member of the German Bundestag Rapporteur René Röspel, Member of the German Bundestag Rapporteur Prof Dr Martin Neumann, Member of the German Bundestag Rapporteur Dr Petra Sitte, Member of the German Bundestag Rapporteur Hans-Josef Fell, Member of the German Bundestag Rapporteur INHALT THE COMMITTEE’ S PREFACE 5 SUMMARY 11 I. INTRODUCTION 35 1. Background and central aspects of the topic 35 2. Commission, objective, and approach 36 3. Cooperation with reporting experts 39 4. Structure of the report 41 5. Use of the term »enhancement« 42 II. HUMAN PERFORMANCE AND ATTEMPTS TO INFLUENCE IT BY PHARMACOLOGICAL MEANS 45 1. Concepts and biological foundations 46 1.1 Human performance 46 1.2 Human abilities 50 1.3 Possibilities and limits of attempts to quantify performance and abilities 51 1.4 Biological foundations 54 2. Approaches and limits to improvement of human abilities 58 3. Pharmacologically active substances 61 3.1 Psychostimulants 62 3.2 Substances used to combat dopamine deficiency 75 3.3 Antidepressants 78 3.4 Anti-dementia agents 81 3.5 Beta-blockers 83 3.6 Possible neuroenhancers of the future 85 4. Other substances: plant-based substances 86 4.1 Substances from the fields of medicinal plants and natural medicine 88 4.2 B vitamins 90 4.3 Unsaturated fatty acids 93 4.4 Tyrosine 94 8 CONTENTS 5. Cognitive Training and other methods 95 5.1 Psychologically based training techniques 95 5.2 Noninvasive technical methods 96 6. Conclusion 98 III. ENHANCEMENT SUBSTANCES: FOODS OR MEDICINES? LEGAL DEFINITION, REGULATORY TREATMENT, AND ROUTES OF DIFFUSION 103 1. Substance definitions and distinctions 104 2. Regulatory treatment of foods 107 2.1 The principle of abuse 107 2.2 Subcategories, marketability 108 2.3 Proof of efficacy and obligations to provide information 110 2.4 Market players: attitudes and behavior 114 3. Regulatory treatment of medicines 118 3.1 The principle of prohibition subject to exemptions 119 3.2 Pharmaceutical research: standards for the acquisition of knowledge and for marketing authorization 120 3.3 Marketability 130 3.4 Provision of information and advertising 133 3.5 Pharmacists and doctors: key players for placing on the market and use of medicines 144 3.6 Cost bearers and healthcare markets 154 4. The consumption side: findings on use of medicines for performance enhancement 167 4.1 Empirical findings on pharmacological performance enhancement 169 4.2 Dealing with potential costs arising from use of (enhancement) substances 174 5. Conclusion 176 IV. THE DEBATE ABOUT ENHANCEMENT IN ETHICS AND THE SOCIAL SCIENCES 183 1. The ethical debate about enhancement 183 1.1 Definition and demarcation problems 184 1.2 Ethical principles according to Beauchamp and Childress 188 1.3 Concerns about the future of human nature 192 CONTENTS 9 2. Perspectives of the social sciences: enhancement as part of a medicalization process 194 2.1 Boundary shifts in the narrow area of medical science: illness, health, healing, improvement 196 2.2 The subject level: acquisition forms between social pressure and self-determination 202 2.3 Socioeconomic boundary shifts: from healthcare to health market 208 3. Conclusion 211 V. PERFORMANCE-ENHANCING AGENTS OF THE FUTURE – A SCENARIO OF EXPANSION 213 1. Development of performance-enhancing agents in the current research and innovation system 215 1.1 Players in pharmacological researchand development 216 1.2 Current development and diffusion routes 223 2. Elements and implications of a scenario of expansion 226 2.1 Current legal restrictions – necessary changes 228 2.2 Premarketing research and development 231 2.3 Requirements of long-term monitoring 237 2.4 Possible consequences for the healthcare system 238 2.5 Repercussions on the system of innovation 241 2.6 Conclusion: possible triggers of the scenario of expansion 243 VI. DOPING AND ENHANCEMENT: SIMILARITIES AND DIFFERENCES BETWEEN SPORT AND WORKING LIFE 245 1. Discussion of doping: arguments and patterns of justification 246 2. Doping spiral: the quantity law and drop-outs 248 3. Pharmacological
Load more

Recommended publications
  • Neuroenhancement in French and Romanian University Students, Motivations and Associated Factors
    International Journal of Environmental Research and Public Health Article Neuroenhancement in French and Romanian University Students, Motivations and Associated Factors Irina Brumboiu 1, Alessandro Porrovecchio 2, Thierry Peze 2 , Remy Hurdiel 2, Irina Cazacu 1 , Cristina Mogosan 1 , Joel Ladner 3 and Marie-Pierre Tavolacci 4,* 1 Cluj-Napoca Unit—The Net-Work of International Francophone Clinical Epidemiology, Iuliu Hatieganu University of Medicine and Pharmacy, 400000 Cluj-Napoca, Romania; [email protected] (I.B.); [email protected] (I.C.); [email protected] (C.M.) 2 Univ. Littoral Côte d’Opale, Univ. Lille Artois ULR 7369—URePSSS—Unité de Recherche Pluridiscipli-Naire Sport Santé Société, F-59375 Dunkerque, France; [email protected] (A.P.); [email protected] (T.P.); [email protected] (R.H.) 3 Clinical Investigation Center 1404 and INSERM 1073, Rouen University Hospital and Rouen Normandie University, 76000 Rouen, France; [email protected] 4 Department of Epidemiology and Health Promotion and INSERM 1073, Rouen University Hospital and Rouen Normandie University, 76000 Rouen, France * Correspondence: [email protected] Abstract: This cross-sectional study aimed to determine the use of neuroenhancers, the motivations and factors associated with their use in French and Romanian university students. Students from two universities in France (Rouen and Opal Coast University) and one in Romania (Cluj-Napoca) were asked to complete a self-administered anonymous questionnaire, either online or on paper, about the use of three different categories of substance: Prescription drugs (methylphenidate, modafinil, and Citation: Brumboiu, I.; Porrovecchio, beta-blockers), drugs of abuse (alcohol, cannabis, cocaine, and amphetamines), and soft enhancers A.; Peze, T.; Hurdiel, R.; Cazacu, I.; (coffee, vitamins, caffeine tablets, and energy drinks).
    [Show full text]
  • Politikszene 19.4
    politik & Ausgabe Nr. 88 kommunikation politikszene 19.4. – 25.4.2006 Schmidt-Deguelle schließt sich WMP an Klaus-Peter Schmidt-Deguelle (55) arbeitet ab sofort als freier Berater („associated partner“) für die WMP Eurocom AG. Der Journalist und Staatssekretär a.D. war langjähriger Berater von Ex-Finanzmi- nister Hans Eichel, dem er schon in Hessen als Regierungssprecher diente. Später beriet Schmidt-Deguelle auch den ehemaligen Arbeitsminister Walter Riester. Er war außerdem Chefredakteur von VOX und Leiter der „ARD-Aktuell“-Redaktion des Hessischen Rundfunks. K.-P. Schmidt-Deguelle Bundestagsverwaltung organisiert sich neu Hans-Joachim Stelzl wird ab Mai neuer Direktor beim Deutschen Bundestag. Er folgt auf Wofgang Zeh, der sich in den Ruhestand verabschiedet. Stelzl leitete zuletzt die Abteilung „Zentrale Dienste“ in der Bundestagsverwaltung. In dieser Position folgt ihm Erdmute Rebhan nach, die bislang die Abteilung „Wissenschaftliche Dienste“ verantwortete. Friedhelm Maier, bisher Leiter der „Parlamentarischen Dienste“, übernimmt die Abteilung von Rebhan. Nachfolger Maiers wird der bisherige Unterabteilungsleiter „Parlamentsdienste“ Hermann-Josef Schreiner. Ganz neu eingerichtet wird die Abteilung „Information“. Designierter Leiter: Hans Leptien, derzeit Unterabteilungsleiter „Wissenschaftliche Hans-Joachim Stelzl Dokumentation“ und ehemaliger Leiter des Pressezentrums von Ex-Bundestagspräsidentin Rita Süssmuth. NEWS +++ Manfred Jäger ist neuer innenpolitischer Sprecher der CDU-Bürgerschaftsfraktion in Hamburg. Er folgt auf Christoph Ahlhaus, der als Staatsrat in die Innen- behörde gewechselt ist (politikszene 86 berichtete). In Verfassungsfragen spricht künftig Kai Voet van Vormizeele für die CDU-Fraktion. Neuer Vorsitzender des Verfassungsausschusses ist A. W. Heinrich Langhein. +++ Wulf Gallert sitzt künftig der Fraktion der Linkspartei.PDS im Landtag Sachsen-Anhalt vor. Gallerts Stellvertreter sind Birke Bull und Angelika Klein.
    [Show full text]
  • Jan Van Aken Stephan Albani Katrin Albsteiger Peter Altmaier Luise Amtsberg Kerstin Andreae Niels Annen Ingrid Arndt-Brauer Rain
    Hans-Joachim Zimmer Hofäckerstraße 36 71364 Winnenden 07195/138575 07195/138574 E-Mail [email protected] H.-J. Zimmer, Hofäckerstraße 36, 71364 Winnenden Einschreiben mit Rückschein Verwaltungsgericht Berlin Kirchstraße 7 10557 Berlin 31. Mai 2017 In der Rechtssache Hans-Joachim Zimmer - Kläger - Hofäckerstraße 36 71364 Winnenden gegen Bundesrepublik Deutschland - Beklagte - Deutscher Bundestag Gemeinschaftlich vertreten durch die Abgeordneten Jan van Aken Stephan Albani Katrin Albsteiger Peter Altmaier Luise Amtsberg Kerstin Andreae Niels Annen Ingrid Arndt-Brauer Rainer Arnold Artur Auernhammer Heike Baehrens Annalena Baerbock Ulrike Bahr Bettina Bähr-Losse Dorothee Bär 2 Heinz-Joachim Barchmann Thomas Bareiß Katarina Barley Doris Barnett Klaus Barthel Norbert Barthle Matthias Bartke Sören Bartol Dietmar Bartsch Bärbel Bas Günter Baumann Marieluise Beck Volker Beck Uwe Beckmeyer Maik Beermann Herbert Behrens Manfred Behrens Veronika Bellmann Sybille Benning André Berghegger Christoph Bergner Ute Bertram Peter Beyer Steffen Bilger Karin Binder Lothar Binding Clemens Binninger Matthias Birkwald Peter Bleser Burkhard Blienert Heidrun Bluhm Maria Böhmer Wolfgang Bosbach Norbert Brackmann Klaus Brähmig Michael Brand Reinhard Brandl Helmut Brandt Franziska Brantner Willi Brase Ralf Brauksiepe Helge Braun 3 Heike Brehmer Ralph Brinkhaus Agnieszka Brugger Karl-Heinz Brunner Christine Buchholz Eva Bulling-Schröter Edelgard Bulmahn Marco Bülow Martin Burkert Cajus Julius Caesar Lars Castellucci Roland Claus Gitta Connemann Jürgen Coße Petra Crone
    [Show full text]
  • Commander's Guide to German Society, Customs, and Protocol
    Headquarters Army in Europe United States Army, Europe, and Seventh Army Pamphlet 360-6* United States Army Installation Management Agency Europe Region Office Heidelberg, Germany 20 September 2005 Public Affairs Commanders Guide to German Society, Customs, and Protocol *This pamphlet supersedes USAREUR Pamphlet 360-6, 8 March 2000. For the CG, USAREUR/7A: E. PEARSON Colonel, GS Deputy Chief of Staff Official: GARY C. MILLER Regional Chief Information Officer - Europe Summary. This pamphlet should be used as a guide for commanders new to Germany. It provides basic information concerning German society and customs. Applicability. This pamphlet applies primarily to commanders serving their first tour in Germany. It also applies to public affairs officers and protocol officers. Forms. AE and higher-level forms are available through the Army in Europe Publishing System (AEPUBS). Records Management. Records created as a result of processes prescribed by this publication must be identified, maintained, and disposed of according to AR 25-400-2. Record titles and descriptions are available on the Army Records Information Management System website at https://www.arims.army.mil. Suggested Improvements. The proponent of this pamphlet is the Office of the Chief, Public Affairs, HQ USAREUR/7A (AEAPA-CI, DSN 370-6447). Users may suggest improvements to this pamphlet by sending DA Form 2028 to the Office of the Chief, Public Affairs, HQ USAREUR/7A (AEAPA-CI), Unit 29351, APO AE 09014-9351. Distribution. B (AEPUBS) (Germany only). 1 AE Pam 360-6 ● 20 Sep 05 CONTENTS Section I INTRODUCTION 1. Purpose 2. References 3. Explanation of Abbreviations 4. General Section II GETTING STARTED 5.
    [Show full text]
  • Top 17 Cases Version 4/27/2020, with Addendum
    2020 DNA Hit of the Year Top 17 Cases Version 4/27/2020, with Addendum * All addenda written by submitters. 1. Headless Outlaw’s Torso in Old Lava Tube Name of Submitter: Clark County Sheriff Bart May Location: Dubois, Idaho, U.S.A. Agency: Clark County Sheriff’s Office, Idaho Date of Crime: 1916 Date and Type of Hit: 2018-2019 (genetic genealogy to match with general family tree); 2018-2019 (familial match with living grandson to confirm family relationship) Executive Summary: 100-year-old unidentified human remains found in an old lava tube in 1979 leads to a cold case identification effort that lasts many years. However, his head was never located, baffling the FBI and other investigators for years. They could only establish that he was of European descent, with reddish-brown hair, and was about 40-years-old at the time of death. His arms, hand, and legs were found in 1991. Over the years, investigators enlisted the help of Idaho State University and its team of forensic genetic genealogists (anthropology students and staffers). This also included experts from the Smithsonian Institution and the FBI. Last year investigators further enlisted the help of the DNA Doe Project, hoping to use DNA and ancestral analysis to identify the man. Experts from Othram, a forensic DNA analysis company, analyzed samples taken from the remains, while a forensic genealogist from the DNA Doe Project worked with her colleagues to build a ‘genealogical tree’. The man’s DNA profile was then uploaded to various genetic genealogy DNA databases for relatives. This led to the man’s living 87-year-old grandson, whose sample was taken and tested to confirm a familial relationship.
    [Show full text]
  • Paper: the Political Economy of Germany in the Sovereign Debt Crisis
    The Political Economy of Germany in the Sovereign Debt Crisis Daniela Schwarzer German Institute for International and Security Affairs (SWP) Paper prepared for Resolving the European Debt Crisis, a conference hosted by the Peterson Institute for International Economics and Bruegel, Chantilly, France, September 13-14, 2011. 1. The German Economic Situation Economic Growth Perspectives and Employment After the downturn in 2008–09, there has been a strong economic recovery in Germany in 2010 and the first half of 2011. But in the context of an economic deceleration expected for the OECD countries, also the German economy will probably slow down considerably in the second half of 2011 and in 2012. Export growth is likely to weaken as key export markets cool down, partly due to fiscal tightening in Germany’s main trading partners. Export growth scored a high 14.4 percent in 2010 and is likely to decelerate to 8 percent in 2011, as a consequence of fiscal tightening and the flattening of the stock cycle in most major markets. Meanwhile, import growth is expected to decrease from 12.8 percent in 2010 to a still strong 6.6 percent in 2011. Domestic demand is also expected to decline as consumers and business are becoming more cautious. Private consumption growth is forecast to accelerate to 1.6 percent in 2011 from 0.4 percent in 2010, but will then stay at around 1.4 percent on average in 2012 to 2015. Employment is expected to expand which will support domestic demand, but real wages are expected to grow only slowly.
    [Show full text]
  • Nootropics for Healthy Individuals
    Trinity College Trinity College Digital Repository Trinity Publications (Newspapers, Yearbooks, The First-Year Papers (2010 - present) Catalogs, etc.) 2015 Nootropics for Healthy Individuals Jin Pyo Jeon Trinity College, Hartford Connecticut, [email protected] Follow this and additional works at: https://digitalrepository.trincoll.edu/fypapers Part of the Chemicals and Drugs Commons Recommended Citation Jeon, Jin Pyo, "Nootropics for Healthy Individuals". The First-Year Papers (2010 - present) (2015). Trinity College Digital Repository, Hartford, CT. https://digitalrepository.trincoll.edu/fypapers/61 Nootropics for Healthy Individuals Jin Pyo Jeon With recent advances in fields like biotechnology and genetic engineering, the concern for a just and equal distribution of human enhancement technologies undoubtedly became one of the most significant ethical dilemmas of the 21st century. And with the sudden rise of cognitive enhancement drug (otherwise called as nootropics) use in society, the need for developing policies to address these dilemmas have now become an urgent issue that the scientific and political community must confront. Once only used by the few with special needs or neurological disorders, nootropics are now being utilized by a significant part of the population for cognitive enhancement, inciting a debate of the regulation and legalization of nootropics. Nonetheless, given the currently known benefits and risks of nootropics, the mechanisms through which nootropics function, and the ineffectiveness of policy restrictions, it would be more pragmatic to inform and allow for the non-prescription uses for some nootropics rather than to restrict its use. Benefits, Risks, and Viability of the Use of Nootropics Among many other nootropics, two drugs have become the de facto nootropics for many healthy individuals: modafinil (commercially known as Provigil) and methylphenidate (commercially known as Ritalin).
    [Show full text]
  • Neuroenhancement in Healthy Adults, Part I: Pharmaceutical
    l Rese ca arc ni h li & C f B o i o l e Journal of a t h n Fond et al., J Clinic Res Bioeth 2015, 6:2 r i c u s o J DOI: 10.4172/2155-9627.1000213 ISSN: 2155-9627 Clinical Research & Bioethics Review Article Open Access Neuroenhancement in Healthy Adults, Part I: Pharmaceutical Cognitive Enhancement: A Systematic Review Fond G1,2*, Micoulaud-Franchi JA3, Macgregor A2, Richieri R3,4, Miot S5,6, Lopez R2, Abbar M7, Lancon C3 and Repantis D8 1Université Paris Est-Créteil, Psychiatry and Addiction Pole University Hospitals Henri Mondor, Inserm U955, Eq 15 Psychiatric Genetics, DHU Pe-psy, FondaMental Foundation, Scientific Cooperation Foundation Mental Health, National Network of Schizophrenia Expert Centers, F-94000, France 2Inserm 1061, University Psychiatry Service, University of Montpellier 1, CHU Montpellier F-34000, France 3POLE Academic Psychiatry, CHU Sainte-Marguerite, F-13274 Marseille, Cedex 09, France 4 Public Health Laboratory, Faculty of Medicine, EA 3279, F-13385 Marseille, Cedex 05, France 5Inserm U1061, Idiopathic Hypersomnia Narcolepsy National Reference Centre, Unit of sleep disorders, University of Montpellier 1, CHU Montpellier F-34000, Paris, France 6Inserm U952, CNRS UMR 7224, Pierre and Marie Curie University, F-75000, Paris, France 7CHU Carémeau, University of Nîmes, Nîmes, F-31000, France 8Department of Psychiatry, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Eschenallee 3, 14050 Berlin, Germany *Corresponding author: Dr. Guillaume Fond, Pole de Psychiatrie, Hôpital A. Chenevier, 40 rue de Mesly, Créteil F-94010, France, Tel: (33)178682372; Fax: (33)178682381; E-mail: [email protected] Received date: January 06, 2015, Accepted date: February 23, 2015, Published date: February 28, 2015 Copyright: © 2015 Fond G, et al.
    [Show full text]
  • Plenarprotokoll 17/45
    Plenarprotokoll 17/45 Deutscher Bundestag Stenografischer Bericht 45. Sitzung Berlin, Mittwoch, den 9. Juni 2010 Inhalt: Tagesordnungspunkt 1 Britta Haßelmann (BÜNDNIS 90/ DIE GRÜNEN) . 4522 D Befragung der Bundesregierung: Ergebnisse der Klausurtagung der Bundesregierung Dr. Wolfgang Schäuble, Bundesminister über den Haushalt 2011 und den Finanz- BMF . 4522 D plan 2010 bis 2014 . 4517 A Bettina Kudla (CDU/CSU) . 4523 C Dr. Wolfgang Schäuble, Bundesminister Dr. Wolfgang Schäuble, Bundesminister BMF . 4517 B BMF . 4523 C Alexander Bonde (BÜNDNIS 90/ Elke Ferner (SPD) . 4524 A DIE GRÜNEN) . 4518 C Dr. Wolfgang Schäuble, Bundesminister Dr. Wolfgang Schäuble, Bundesminister BMF . 4524 B BMF . 4518 D Carsten Schneider (Erfurt) (SPD) . 4519 B Tagesordnungspunkt 2: Dr. Wolfgang Schäuble, Bundesminister BMF . 4519 C Fragestunde (Drucksachen 17/1917, 17/1951) . 4524 C Axel E. Fischer (Karlsruhe-Land) (CDU/CSU) . 4520 A Dringliche Frage 1 Dr. Wolfgang Schäuble, Bundesminister Elvira Drobinski-Weiß (SPD) BMF . 4520 A Konsequenzen aus Verunreinigungen und Alexander Ulrich (DIE LINKE) . 4520 B Ausbringung von mit NK603 verunreinig- Dr. Wolfgang Schäuble, Bundesminister tem Saatgut in sieben Bundesländern BMF . 4520 C Antwort Joachim Poß (SPD) . 4521 A Dr. Gerd Müller, Parl. Staatssekretär BMELV . 4524 C Dr. Wolfgang Schäuble, Bundesminister Zusatzfragen BMF . 4521 B Elvira Drobinski-Weiß (SPD) . 4525 A Dr. h. c. Jürgen Koppelin (FDP) . 4521 D Dr. Christel Happach-Kasan (FDP) . 4525 C Friedrich Ostendorff (BÜNDNIS 90/ Dr. Wolfgang Schäuble, Bundesminister DIE GRÜNEN) . 4526 A BMF . 4522 A Kerstin Tack (SPD) . 4526 D Rolf Schwanitz (SPD) . 4522 B Cornelia Behm (BÜNDNIS 90/ DIE GRÜNEN) . 4527 C Dr. Wolfgang Schäuble, Bundesminister Bärbel Höhn (BÜNDNIS 90/ BMF . 4522 B DIE GRÜNEN) .
    [Show full text]
  • Deutscher Bundestag
    AUSZUG Plenarprotokoll 16/70 Deutscher Bundestag Stenografischer Bericht 70. Sitzung Berlin, Donnerstag, den 30. November 2006 Inhalt: Begrüßung des Präsidenten der Parlamentari- der Fraktion der FDP: Ratifikation des schen Versammlung des Europarates, Herrn 12. Zusatzprotokolls zur Europäischen van der Linden . 6877 A Menschenrechtskonvention (Drucksache 16/3145) . 6878 C Begrüßung des neuen Abgeordneten Hans Peter Thul . 6877 D d) Antrag der Abgeordneten Markus Löning, Michael Link (Heilbronn), Christian Erweiterung und Abwicklung der Tagesord- Ahrendt, weiterer Abgeordneter und der nung. 6877 D Fraktion der FDP: Eine Grundrechte- Absetzung der Tagesordnungspunkte 3 g und agentur der EU wird nicht gebraucht 33 a . 6878 A (Drucksache 16/3621) . 6878 C Nachträgliche Ausschussüberweisung . 6878 A e) Antrag der Abgeordneten Volker Beck (Köln), Rainder Steenblock, Omid Nouripour, weiterer Abgeordneter und der Tagesordnungspunkt 3: Fraktion des BÜNDNISSES 90/DIE GRÜNEN: Die Rechte der Bürgerinnen a) Antrag der Abgeordneten Erika Steinbach, und Bürger in der EU stärken – Man- Holger Haibach, Carl-Eduard von dat der Grundrechteagentur sinnvoll Bismarck, weiterer Abgeordneter und der ausgestalten Fraktion der CDU/CSU sowie der Abge- (Drucksache 16/3617) . 6878 D ordneten Christoph Strässer, Angelika Graf (Rosenheim), Niels Annen, weiterer f) Antrag der Abgeordneten Volker Beck Abgeordneter und der Fraktion der SPD: (Köln), Marieluise Beck (Bremen), Grietje Stärkung der Menschenrechtspolitik Bettin, weiterer Abgeordneter und der der Europäischen
    [Show full text]
  • Die SPD-Fraktion Im Überblick
    unser projekt heisst zukunft Die SPD-Fraktion im Überblick .................................................................................................................. .................................................................................................................. ..................................................... Funktionen und Strukturen ..................................................... www.spdfraktion.de die spd-fraktion im überblick Der Geschäftsführende ................................................................................................................................Fraktionsvorstand ................................................................................................................................ Der Fraktionsvorsitzende Dr. Frank-Walter Steinmeier Die stellvertretenden Fraktionsvorsitzenden Dr. h.c. Gernot Erler Elke Ferner Hubertus Heil Außenpolitik, Verteidi- Gesundheit, Soziales Wirtschaft und Techno- gungs-/Sicherheitspoli- logie, Arbeit, Tourismus tik, Entwicklungspolitik, Menschenrechte die spd-fraktion im überblick Der Geschäftsführende ................................................................................................................................Fraktionsvorstand ................................................................................................................................ Die stellvertretenden Fraktionsvorsitzenden Ulrich Kelber Christine Lambrecht Joachim Poß Umwelt, Naturschutz Inneres, Recht, Sport, Finanzen, Haushalt und Reaktorsicherheit,
    [Show full text]
  • Plenarprotokoll 16/220
    Plenarprotokoll 16/220 Deutscher Bundestag Stenografischer Bericht 220. Sitzung Berlin, Donnerstag, den 7. Mai 2009 Inhalt: Glückwünsche zum Geburtstag der Abgeord- ter und der Fraktion DIE LINKE: neten Walter Kolbow, Dr. Hermann Scheer, Bundesverantwortung für den Steu- Dr. h. c. Gernot Erler, Dr. h. c. Hans ervollzug wahrnehmen Michelbach und Rüdiger Veit . 23969 A – zu dem Antrag der Abgeordneten Dr. Erweiterung und Abwicklung der Tagesord- Barbara Höll, Dr. Axel Troost, nung . 23969 B Dr. Gregor Gysi, Oskar Lafontaine und der Fraktion DIE LINKE: Steuermiss- Absetzung des Tagesordnungspunktes 38 f . 23971 A brauch wirksam bekämpfen – Vor- handene Steuerquellen erschließen Tagesordnungspunkt 15: – zu dem Antrag der Abgeordneten Dr. a) Erste Beratung des von den Fraktionen der Barbara Höll, Wolfgang Nešković, CDU/CSU und der SPD eingebrachten Ulla Lötzer, weiterer Abgeordneter Entwurfs eines Gesetzes zur Bekämp- und der Fraktion DIE LINKE: Steuer- fung der Steuerhinterziehung (Steuer- hinterziehung bekämpfen – Steuer- hinterziehungsbekämpfungsgesetz) oasen austrocknen (Drucksache 16/12852) . 23971 A – zu dem Antrag der Abgeordneten b) Beschlussempfehlung und Bericht des Fi- Christine Scheel, Kerstin Andreae, nanzausschusses Birgitt Bender, weiterer Abgeordneter und der Fraktion BÜNDNIS 90/DIE – zu dem Antrag der Fraktionen der GRÜNEN: Keine Hintertür für Steu- CDU/CSU und der SPD: Steuerhin- erhinterzieher terziehung bekämpfen (Drucksachen 16/11389, 16/11734, 16/9836, – zu dem Antrag der Abgeordneten Dr. 16/9479, 16/9166, 16/9168, 16/9421, Volker Wissing, Dr. Hermann Otto 16/12826) . 23971 B Solms, Carl-Ludwig Thiele, weiterer Abgeordneter und der Fraktion der Lothar Binding (Heidelberg) (SPD) . 23971 D FDP: Steuervollzug effektiver ma- Dr. Hermann Otto Solms (FDP) . 23973 A chen Eduard Oswald (CDU/CSU) .
    [Show full text]